Legend Biotech (LEGN) Income from Discontinued Operations (2022 - 2025)
Legend Biotech (LEGN) posted Income from Discontinued Operations of 11200000.0 for Q4 2025, up 21.13% on a QoQ basis from 14200000.0 in Q4 2024, and up 21.13% year-over-year from 9246511.63 in Q4 2024.
Legend Biotech (LEGN) Income from Discontinued Operations (2022 - 2025) Analysis & Trends
Legend Biotech's Income from Discontinued Operations history runs 4 years deep, the most recent figure standing at 11200000.0 for Q4 2025.
- Quarterly Income from Discontinued Operations rose 21.13% year-over-year to 11200000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 25551006.0 (changed N/A YoY) and the FY2025 annual result came in at 14200000.0, up 24.87% from the prior year.
- Income from Discontinued Operations was 11200000.0 for Q4 2025 at Legend Biotech, up from 14200000.0 in the prior quarter.
- Across five years, Income from Discontinued Operations topped out at 1994.0 in Q4 2023 and bottomed at 14200000.0 in Q4 2024.
- A 4-year average of 6387751.5 and a median of 5676500.0 in 2022 frame the typical range for Income from Discontinued Operations.
- Annual changes were most pronounced in 2023 — Income from Discontinued Operations soared 101.3% — and 2024, when it slumped 712236.41%.
- Legend Biotech's Income from Discontinued Operations stood at 153000.0 in 2022, then jumped by 101.3% to 1994.0 in 2023, then slumped by 712236.41% to 14200000.0 in 2024, then rose by 21.13% to 11200000.0 in 2025.
- Business Quant data shows LEGN's Income from Discontinued Operations at 11200000.0 in Q4 2025, 14200000.0 in Q4 2024, and 1994.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | -11.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.20 Mn |
| Dec 31, 2024 | -14.20 Mn |
| Dec 31, 2023 | 1,994.00 |
| Dec 31, 2022 | -153,000.00 |